25 XP   0   0   10

Shenzhen Chipscreen Biosciences Co
Buy, Hold or Sell?

Let's analyse Chipscreen together

PenkeI guess you are interested in Shenzhen Chipscreen Biosciences Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shenzhen Chipscreen Biosciences Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shenzhen Chipscreen Biosciences Co

I send you an email if I find something interesting about Shenzhen Chipscreen Biosciences Co.

Quick analysis of Chipscreen (30 sec.)










What can you expect buying and holding a share of Chipscreen? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
95.2%

What is your share worth?

Current worth
¥4.16
Expected worth in 1 year
¥4.48
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
¥0.37
Return On Investment
1.8%

For what price can you sell your share?

Current Price per Share
¥21.10
Expected price per share
¥16.18 - ¥21.64
How sure are you?
50%

1. Valuation of Chipscreen (5 min.)




Live pricePrice per Share (EOD)

¥21.10

Intrinsic Value Per Share

¥-4.95 - ¥-5.64

Total Value Per Share

¥-0.80 - ¥-1.49

2. Growth of Chipscreen (5 min.)




Is Chipscreen growing?

Current yearPrevious yearGrowGrow %
How rich?$236.1m$208.8m$25.8m11.0%

How much money is Chipscreen making?

Current yearPrevious yearGrowGrow %
Making money$3m$603.6k$2.4m80.3%
Net Profit Margin13.3%-1.5%--

How much money comes from the company's main activities?

3. Financial Health of Chipscreen (5 min.)




What can you expect buying and holding a share of Chipscreen? (5 min.)

Welcome investor! Chipscreen's management wants to use your money to grow the business. In return you get a share of Chipscreen.

What can you expect buying and holding a share of Chipscreen?

First you should know what it really means to hold a share of Chipscreen. And how you can make/lose money.

Speculation

The Price per Share of Chipscreen is ¥21.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chipscreen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chipscreen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.16. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chipscreen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.010.0%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share-0.010.0%0.010.1%0.010.1%0.030.1%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.010.0%0.010.1%0.010.1%0.030.1%0.030.1%
Usd Price Per Share3.03-3.32-3.28-4.52-4.30-
Price to Earnings Ratio-117.28--61.13--151.83-1,104.43-1,051.84-
Price-to-Total Gains Ratio-544.46-689.10--461.68-6,661.92-6,661.92-
Price to Book Ratio5.28-5.85-6.52-8.99-8.56-
Price-to-Total Gains Ratio-544.46-689.10--461.68-6,661.92-6,661.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.91391
Number of shares343
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.010.03
Gains per Quarter (343 shares)4.4010.08
Gains per Year (343 shares)17.6140.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1215813930
24312627970
3646443118110
4962624158150
51177805197190
61393985236230
7151081166276270
8171241347315310
9191391528354350
10221551709394390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%10.010.00.050.0%11.010.00.052.4%11.010.00.052.4%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%11.09.00.055.0%11.09.01.052.4%11.09.01.052.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.01.095.2%20.00.01.095.2%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%14.06.00.070.0%14.06.01.066.7%14.06.01.066.7%

Fundamentals of Chipscreen

About Shenzhen Chipscreen Biosciences Co

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals. It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-generation insulin sensitizing candidate drug for the treatment of type 2 diabetes mellitus; chiauranib, an aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor; and CS12192, a highly selective JAK3 kinase inhibitor. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China.

Fundamental data was last updated by Penke on 2024-04-18 18:15:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shenzhen Chipscreen Biosciences Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chipscreen earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -11.0% means that ¥-0.11 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is -11.0%. The company is making a huge loss. -2
  • The TTM is 13.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-11.0%TTM13.3%-24.3%
TTM13.3%YOY-1.5%+14.8%
TTM13.3%5Y6.9%+6.4%
5Y6.9%10Y7.3%-0.4%
1.1.2. Return on Assets

Shows how efficient Chipscreen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.6% Return on Assets means that Chipscreen generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is -0.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM0.7%-1.3%
TTM0.7%YOY0.1%+0.6%
TTM0.7%5Y0.4%+0.3%
5Y0.4%10Y0.4%+0.0%
1.1.3. Return on Equity

Shows how efficient Chipscreen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.1% Return on Equity means Chipscreen generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is -1.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM1.1%-2.2%
TTM1.1%YOY0.3%+0.8%
TTM1.1%5Y0.6%+0.5%
5Y0.6%10Y0.7%0.0%

1.2. Operating Efficiency of Shenzhen Chipscreen Biosciences Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chipscreen is operating .

  • Measures how much profit Chipscreen makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-25.4%+25.4%
TTM-25.4%YOY-2.5%-22.9%
TTM-25.4%5Y-4.5%-20.8%
5Y-4.5%10Y-4.0%-0.5%
1.2.2. Operating Ratio

Measures how efficient Chipscreen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are ¥1.15 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 1.148. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.441. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.148TTM1.441-0.293
TTM1.441YOY1.078+0.363
TTM1.4415Y1.114+0.326
5Y1.11410Y1.108+0.007

1.3. Liquidity of Shenzhen Chipscreen Biosciences Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chipscreen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.89 means the company has ¥2.89 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 2.892. The company is able to pay all its short-term debts. +1
  • The TTM is 2.758. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.892TTM2.758+0.133
TTM2.758YOY2.108+0.650
TTM2.7585Y4.142-1.384
5Y4.14210Y3.945+0.197
1.3.2. Quick Ratio

Measures if Chipscreen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.06 means the company can pay off ¥1.06 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 1.056. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.933. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.056TTM0.933+0.123
TTM0.933YOY0.647+0.285
TTM0.9335Y0.752+0.180
5Y0.75210Y0.716+0.036

1.4. Solvency of Shenzhen Chipscreen Biosciences Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chipscreen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chipscreen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Chipscreen assets are financed with 46.6% credit (debt) and the remaining percentage (100% - 46.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 0.466. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.466TTM0.458+0.009
TTM0.458YOY0.383+0.075
TTM0.4585Y0.287+0.171
5Y0.28710Y0.273+0.014
1.4.2. Debt to Equity Ratio

Measures if Chipscreen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 87.3% means that company has ¥0.87 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The MRQ is 0.873. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.864. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.873TTM0.864+0.009
TTM0.864YOY0.648+0.216
TTM0.8645Y0.463+0.401
5Y0.46310Y0.441+0.022

2. Market Valuation of Shenzhen Chipscreen Biosciences Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chipscreen generates.

  • Above 15 is considered overpriced but always compare Chipscreen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -117.28 means the investor is paying ¥-117.28 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The EOD is -112.734. Based on the earnings, the company is expensive. -2
  • The MRQ is -117.275. Based on the earnings, the company is expensive. -2
  • The TTM is -61.126. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-112.734MRQ-117.275+4.541
MRQ-117.275TTM-61.126-56.149
TTM-61.126YOY-151.833+90.707
TTM-61.1265Y1,104.432-1,165.557
5Y1,104.43210Y1,051.840+52.592
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The EOD is -23.525. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.473. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -28.799. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23.525MRQ-24.473+0.948
MRQ-24.473TTM-28.799+4.326
TTM-28.799YOY-46.546+17.747
TTM-28.7995Y-56.288+27.489
5Y-56.28810Y-53.608-2.680
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chipscreen is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shenzhen Chipscreen Biosciences Co:

  • The EOD is 5.075. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.280. Based on the equity, the company is overpriced. -1
  • The TTM is 5.850. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.075MRQ5.280-0.204
MRQ5.280TTM5.850-0.570
TTM5.850YOY6.524-0.674
TTM5.8505Y8.993-3.144
5Y8.99310Y8.565+0.428
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shenzhen Chipscreen Biosciences Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0540.082-166%0.096-156%0.208-126%0.198-127%
Book Value Per Share--4.1574.132+1%3.677+13%3.456+20%3.292+26%
Current Ratio--2.8922.758+5%2.108+37%4.142-30%3.945-27%
Debt To Asset Ratio--0.4660.458+2%0.383+22%0.287+62%0.273+71%
Debt To Equity Ratio--0.8730.864+1%0.648+35%0.463+89%0.441+98%
Dividend Per Share--0.0130.011+16%0.007+81%0.005+174%0.005+188%
Eps---0.0470.054-187%0.011-544%0.022-316%0.021-320%
Free Cash Flow Per Share---0.224-0.235+5%-0.217-3%-0.175-22%-0.175-22%
Free Cash Flow To Equity Per Share---0.224-0.045-80%0.402-156%0.011-2158%0.011-2158%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.645--------
Intrinsic Value_10Y_min---4.953--------
Intrinsic Value_1Y_max---0.711--------
Intrinsic Value_1Y_min---0.699--------
Intrinsic Value_3Y_max---2.027--------
Intrinsic Value_3Y_min---1.937--------
Intrinsic Value_5Y_max---3.208--------
Intrinsic Value_5Y_min---2.987--------
Market Cap8678155868.800-4%9027749825.6009876029279.600-9%9779376832.720-8%13457310901.760-33%12816486573.105-30%
Net Profit Margin---0.1100.133-182%-0.015-86%0.069-260%0.073-250%
Operating Margin----0.2540%-0.0250%-0.0450%-0.0400%
Operating Ratio--1.1481.441-20%1.078+7%1.114+3%1.108+4%
Pb Ratio5.075-4%5.2805.850-10%6.524-19%8.993-41%8.565-38%
Pe Ratio-112.734+4%-117.275-61.126-48%-151.833+29%1104.432-111%1051.840-111%
Price Per Share21.100-4%21.95024.013-9%23.778-8%32.720-33%31.162-30%
Price To Free Cash Flow Ratio-23.525+4%-24.473-28.799+18%-46.546+90%-56.288+130%-53.608+119%
Price To Total Gains Ratio-523.374+4%-544.458689.098-179%-461.684-15%6661.915-108%6661.915-108%
Quick Ratio--1.0560.933+13%0.647+63%0.752+40%0.716+47%
Return On Assets---0.0060.007-187%0.001-801%0.004-245%0.004-253%
Return On Equity---0.0110.011-201%0.003-503%0.006-275%0.007-269%
Total Gains Per Share---0.0400.093-143%0.103-139%0.213-119%0.203-120%
Usd Book Value--236136619.916234676854.797+1%208828925.189+13%196313606.559+20%186965339.580+26%
Usd Book Value Change Per Share---0.0070.011-166%0.013-156%0.029-126%0.027-127%
Usd Book Value Per Share--0.5740.571+1%0.508+13%0.477+20%0.455+26%
Usd Dividend Per Share--0.0020.002+16%0.001+81%0.001+174%0.001+188%
Usd Eps---0.0060.007-187%0.001-544%0.003-316%0.003-320%
Usd Free Cash Flow---12735770.618-13337087.544+5%-12321007.361-3%-7937335.135-38%-7559366.796-41%
Usd Free Cash Flow Per Share---0.031-0.032+5%-0.030-3%-0.024-22%-0.024-22%
Usd Free Cash Flow To Equity Per Share---0.031-0.006-80%0.056-156%0.002-2158%0.002-2158%
Usd Market Cap1198453325.481-4%1246732250.9151363879643.513-9%1350531940.599-8%1858454635.533-33%1769956795.746-30%
Usd Price Per Share2.914-4%3.0313.316-9%3.284-8%4.519-33%4.303-30%
Usd Profit---2657708.8453067150.502-187%603662.955-540%1234265.208-315%1207862.551-320%
Usd Revenue--24184237.65418081094.408+34%18296160.460+32%13308488.788+82%12877956.322+88%
Usd Total Gains Per Share---0.0060.013-143%0.014-139%0.029-119%0.028-120%
 EOD+3 -5MRQTTM+15 -19YOY+10 -245Y+10 -2410Y+10 -24

3.2. Fundamental Score

Let's check the fundamental score of Shenzhen Chipscreen Biosciences Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-112.734
Price to Book Ratio (EOD)Between0-15.075
Net Profit Margin (MRQ)Greater than0-0.110
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.056
Current Ratio (MRQ)Greater than12.892
Debt to Asset Ratio (MRQ)Less than10.466
Debt to Equity Ratio (MRQ)Less than10.873
Return on Equity (MRQ)Greater than0.15-0.011
Return on Assets (MRQ)Greater than0.05-0.006
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shenzhen Chipscreen Biosciences Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.654
Ma 20Greater thanMa 5019.827
Ma 50Greater thanMa 10017.956
Ma 100Greater thanMa 20019.401
OpenGreater thanClose20.730
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,203,249
Total Liabilities1,493,354
Total Stockholder Equity1,709,896
 As reported
Total Liabilities 1,493,354
Total Stockholder Equity+ 1,709,896
Total Assets = 3,203,249

Assets

Total Assets3,203,249
Total Current Assets1,130,087
Long-term Assets2,073,163
Total Current Assets
Cash And Cash Equivalents 375,438
Short-term Investments 216,717
Net Receivables 195,880
Inventory 47,129
Other Current Assets 260,347
Total Current Assets  (as reported)1,130,087
Total Current Assets  (calculated)1,095,511
+/- 34,576
Long-term Assets
Property Plant Equipment 1,066,076
Intangible Assets 582,548
Long-term Assets Other 27,906
Long-term Assets  (as reported)2,073,163
Long-term Assets  (calculated)1,676,530
+/- 396,633

Liabilities & Shareholders' Equity

Total Current Liabilities390,805
Long-term Liabilities1,102,548
Total Stockholder Equity1,709,896
Total Current Liabilities
Short Long Term Debt 170,724
Accounts payable 9,025
Other Current Liabilities 1,091
Total Current Liabilities  (as reported)390,805
Total Current Liabilities  (calculated)180,840
+/- 209,966
Long-term Liabilities
Long term Debt 899,169
Capital Lease Obligations Min Short Term Debt10,063
Long-term Liabilities Other 92,828
Long-term Liabilities  (as reported)1,102,548
Long-term Liabilities  (calculated)1,002,061
+/- 100,488
Total Stockholder Equity
Retained Earnings 117,582
Total Stockholder Equity (as reported)1,709,896
Total Stockholder Equity (calculated)117,582
+/- 1,592,314
Other
Capital Stock411,287
Common Stock Shares Outstanding 411,287
Net Debt 694,455
Net Invested Capital 2,779,788
Net Working Capital 739,281
Property Plant and Equipment Gross 1,066,076



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-03-31
> Total Assets 
0
768,964
827,845
1,670,026
1,691,423
1,661,960
1,685,110
1,702,009
1,726,271
1,797,652
1,855,668
1,742,288
1,894,406
2,067,471
2,215,781
2,741,365
2,895,799
3,009,325
3,161,153
3,154,224
3,203,249
3,203,2493,154,2243,161,1533,009,3252,895,7992,741,3652,215,7812,067,4711,894,4061,742,2881,855,6681,797,6521,726,2711,702,0091,685,1101,661,9601,691,4231,670,026827,845768,9640
   > Total Current Assets 
0
247,675
286,552
1,108,137
1,072,230
967,653
916,441
869,033
769,060
778,552
789,687
648,072
638,821
669,653
669,653
1,127,300
1,184,135
1,253,859
1,136,672
1,092,224
1,130,087
1,130,0871,092,2241,136,6721,253,8591,184,1351,127,300669,653669,653638,821648,072789,687778,552769,060869,033916,441967,6531,072,2301,108,137286,552247,6750
       Cash And Cash Equivalents 
0
208,384
156,477
377,256
376,150
384,642
342,190
260,580
318,722
360,281
351,702
298,133
300,167
522,597
370,289
585,428
508,594
609,061
496,760
361,592
375,438
375,438361,592496,760609,061508,594585,428370,289522,597300,167298,133351,702360,281318,722260,580342,190384,642376,150377,256156,477208,3840
       Short-term Investments 
0
0
0
0
4,022
0
0
0
261,868
221,174
220,270
171,020
82,079
10,017
98,363
292,634
291,066
167,182
170,272
271,635
216,717
216,717271,635170,272167,182291,066292,63498,36310,01782,079171,020220,270221,174261,8680004,0220000
       Net Receivables 
0
23,117
40,654
43,243
80,326
46,266
47,565
49,301
47,994
45,529
62,931
50,483
120,617
84,577
84,577
93,110
168,242
169,596
185,962
144,669
195,880
195,880144,669185,962169,596168,24293,11084,57784,577120,61750,48362,93145,52947,99449,30147,56546,26680,32643,24340,65423,1170
       Other Current Assets 
0
2,445
53,375
632,929
5,749
524,398
10,414
546,608
7,132
135,037
6,397
111,136
18,433
13,133
13,133
129,753
187,758
272,224
12,600
256,115
260,347
260,347256,11512,600272,224187,758129,75313,13313,13318,433111,1366,397135,0377,132546,60810,414524,3985,749632,92953,3752,4450
   > Long-term Assets 
0
521,289
541,293
561,890
619,192
694,306
768,669
832,975
957,211
1,019,100
1,065,981
1,094,216
1,255,585
1,323,540
1,546,128
1,614,064
1,711,664
1,755,465
2,024,481
2,062,000
2,073,163
2,073,1632,062,0002,024,4811,755,4651,711,6641,614,0641,546,1281,323,5401,255,5851,094,2161,065,9811,019,100957,211832,975768,669694,306619,192561,890541,293521,2890
       Property Plant Equipment 
0
312,275
326,215
335,271
379,988
443,719
493,111
540,596
586,282
630,019
651,137
665,436
698,988
990,951
990,951
1,008,133
1,100,020
1,114,302
1,087,844
1,074,039
1,066,076
1,066,0761,074,0391,087,8441,114,3021,100,0201,008,133990,951990,951698,988665,436651,137630,019586,282540,596493,111443,719379,988335,271326,215312,2750
       Intangible Assets 
0
184,051
189,639
193,323
155,758
212,188
176,566
232,418
262,056
275,509
302,896
330,512
356,077
381,405
404,427
435,924
466,969
497,903
543,388
562,837
582,548
582,548562,837543,388497,903466,969435,924404,427381,405356,077330,512302,896275,509262,056232,418176,566212,188155,758193,323189,639184,0510
       Other Assets 
0
145,673
152,370
164,414
122,480
135,704
162,209
180,874
241,970
261,665
289,013
304,075
340,421
315,332
315,332
370,437
0
410,649
464,305
0
0
00464,305410,6490370,437315,332315,332340,421304,075289,013261,665241,970180,874162,209135,704122,480164,414152,370145,6730
> Total Liabilities 
0
290,588
328,618
222,292
245,096
210,441
207,441
207,712
232,441
304,402
332,076
381,007
476,792
644,114
798,307
1,109,267
1,320,099
1,433,831
1,381,173
1,422,291
1,493,354
1,493,3541,422,2911,381,1731,433,8311,320,0991,109,267798,307644,114476,792381,007332,076304,402232,441207,712207,441210,441245,096222,292328,618290,5880
   > Total Current Liabilities 
0
115,698
151,033
108,737
137,306
106,173
109,862
117,124
146,887
211,251
245,913
299,979
293,839
456,090
456,090
340,987
540,541
640,366
369,501
351,429
390,805
390,805351,429369,501640,366540,541340,987456,090456,090293,839299,979245,913211,251146,887117,124109,862106,173137,306108,737151,033115,6980
       Short-term Debt 
0
20,000
50,000
58,738
63,180
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000063,18058,73850,00020,0000
       Short Long Term Debt 
0
20,000
50,000
58,738
63,180
47,549
37,447
36,324
37,194
96,624
126,615
179,314
145,174
175,500
313,164
194,525
210,780
219,935
148,554
132,325
170,724
170,724132,325148,554219,935210,780194,525313,164175,500145,174179,314126,61596,62437,19436,32437,44747,54963,18058,73850,00020,0000
       Accounts payable 
0
61
51
1,184
222
133
264
181
3,541
87
209
1,438
2,231
1,323
1,323
822
324
5,950
1,106
4,701
9,025
9,0254,7011,1065,9503248221,3231,3232,2311,438209873,5411812641332221,18451610
       Other Current Liabilities 
0
30,777
39,654
4,616
45,297
51,498
39,152
64,242
57,661
99,284
85,777
93,306
82,945
94,108
94,108
118,823
82
392,606
127,227
1,471
1,091
1,0911,471127,227392,60682118,82394,10894,10882,94593,30685,77799,28457,66164,24239,15251,49845,2974,61639,65430,7770
   > Long-term Liabilities 
0
174,890
177,586
113,554
107,790
104,268
97,579
90,587
85,554
93,152
86,163
81,028
182,953
353,940
342,217
768,280
779,558
793,465
1,011,672
1,070,862
1,102,548
1,102,5481,070,8621,011,672793,465779,558768,280342,217353,940182,95381,02886,16393,15285,55490,58797,579104,268107,790113,554177,586174,8900
       Other Liabilities 
0
69,890
72,645
72,292
70,897
71,744
68,307
64,567
62,786
71,426
69,420
69,267
176,655
171,461
171,461
169,430
180,249
174,705
191,823
0
0
00191,823174,705180,249169,430171,461171,461176,65569,26769,42071,42662,78664,56768,30771,74470,89772,29272,64569,8900
       Deferred Long Term Liability 
0
120,956
127,108
131,253
88,278
97,750
116,985
126,887
139,079
154,002
183,414
212,538
145,934
197,822
197,822
235,842
0
306,129
355,233
0
0
00355,233306,1290235,842197,822197,822145,934212,538183,414154,002139,079126,887116,98597,75088,278131,253127,108120,9560
> Total Stockholder Equity
450,552
478,376
499,227
1,447,735
1,446,327
1,451,519
1,477,669
1,494,297
1,493,830
1,493,249
1,523,591
1,361,280
1,417,614
1,423,357
1,417,474
1,568,762
1,515,467
1,454,331
1,779,980
1,731,932
1,709,896
1,709,8961,731,9321,779,9801,454,3311,515,4671,568,7621,417,4741,423,3571,417,6141,361,2801,523,5911,493,2491,493,8301,494,2971,477,6691,451,5191,446,3271,447,735499,227478,376450,552
   Common Stock
0
360,000
360,000
410,000
410,000
410,000
410,000
410,000
410,000
410,000
410,721
410,721
410,721
410,721
410,721
410,721
0
411,117
411,287
0
0
00411,287411,1170410,721410,721410,721410,721410,721410,721410,000410,000410,000410,000410,000410,000410,000360,000360,0000
   Retained Earnings Total Equity000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
25
47
-287
3,427
3,427
131,423
130,049
129,090
132,405
0
0
00132,405129,090130,049131,4233,4273,427-28747250000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue523,710
Cost of Revenue-56,969
Gross Profit466,741466,741
 
Operating Income (+$)
Gross Profit466,741
Operating Expense-688,296
Operating Income-164,586-221,554
 
Operating Expense (+$)
Research Development270,445
Selling General Administrative305,596
Selling And Marketing Expenses-
Operating Expense688,296576,041
 
Net Interest Income (+$)
Interest Income16,771
Interest Expense-34,881
Other Finance Cost-150
Net Interest Income-18,260
 
Pretax Income (+$)
Operating Income-164,586
Net Interest Income-18,260
Other Non-Operating Income Expenses-
Income Before Tax (EBT)97,019-164,586
EBIT - interestExpense = -34,881
88,839
123,719
Interest Expense34,881
Earnings Before Interest and Taxes (EBIT)-131,900
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax97,019
Tax Provision-47,831
Net Income From Continuing Ops49,18849,188
Net Income88,839
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,260
 

Technical Analysis of Chipscreen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chipscreen. The general trend of Chipscreen is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chipscreen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shenzhen Chipscreen Biosciences Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 20.98 < 20.98 < 21.64.

The bearish price targets are: 18.96 > 18.37 > 16.18.

Tweet this
Shenzhen Chipscreen Biosciences Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shenzhen Chipscreen Biosciences Co. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shenzhen Chipscreen Biosciences Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shenzhen Chipscreen Biosciences Co. The current macd is 0.764208.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chipscreen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Chipscreen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Chipscreen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shenzhen Chipscreen Biosciences Co Daily Moving Average Convergence/Divergence (MACD) ChartShenzhen Chipscreen Biosciences Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shenzhen Chipscreen Biosciences Co. The current adx is 23.94.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Chipscreen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Shenzhen Chipscreen Biosciences Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shenzhen Chipscreen Biosciences Co. The current sar is 21.33.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shenzhen Chipscreen Biosciences Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shenzhen Chipscreen Biosciences Co. The current rsi is 64.65. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Shenzhen Chipscreen Biosciences Co Daily Relative Strength Index (RSI) ChartShenzhen Chipscreen Biosciences Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shenzhen Chipscreen Biosciences Co. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chipscreen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shenzhen Chipscreen Biosciences Co Daily Stochastic Oscillator ChartShenzhen Chipscreen Biosciences Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shenzhen Chipscreen Biosciences Co. The current cci is 60.22.

Shenzhen Chipscreen Biosciences Co Daily Commodity Channel Index (CCI) ChartShenzhen Chipscreen Biosciences Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shenzhen Chipscreen Biosciences Co. The current cmo is 33.79.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shenzhen Chipscreen Biosciences Co Daily Chande Momentum Oscillator (CMO) ChartShenzhen Chipscreen Biosciences Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shenzhen Chipscreen Biosciences Co. The current willr is -20.14925373.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Chipscreen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shenzhen Chipscreen Biosciences Co Daily Williams %R ChartShenzhen Chipscreen Biosciences Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shenzhen Chipscreen Biosciences Co.

Shenzhen Chipscreen Biosciences Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shenzhen Chipscreen Biosciences Co. The current atr is 0.86702159.

Shenzhen Chipscreen Biosciences Co Daily Average True Range (ATR) ChartShenzhen Chipscreen Biosciences Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shenzhen Chipscreen Biosciences Co. The current obv is 159,487,209.

Shenzhen Chipscreen Biosciences Co Daily On-Balance Volume (OBV) ChartShenzhen Chipscreen Biosciences Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shenzhen Chipscreen Biosciences Co. The current mfi is 68.29.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shenzhen Chipscreen Biosciences Co Daily Money Flow Index (MFI) ChartShenzhen Chipscreen Biosciences Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shenzhen Chipscreen Biosciences Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shenzhen Chipscreen Biosciences Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shenzhen Chipscreen Biosciences Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.654
Ma 20Greater thanMa 5019.827
Ma 50Greater thanMa 10017.956
Ma 100Greater thanMa 20019.401
OpenGreater thanClose20.730
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chipscreen with someone you think should read this too:
  • Are you bullish or bearish on Chipscreen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chipscreen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shenzhen Chipscreen Biosciences Co

I send you an email if I find something interesting about Shenzhen Chipscreen Biosciences Co.


Comments

How you think about this?

Leave a comment

Stay informed about Shenzhen Chipscreen Biosciences Co.

Receive notifications about Shenzhen Chipscreen Biosciences Co in your mailbox!